Table 4.
Collagen and collagen cross-links
| CON | MRT | HRT | ||||
|---|---|---|---|---|---|---|
| 0 mths (n = 10) | 12 mths (n = 10) | 0 mths (n = 13) | 12 mths (n = 13) | 0 mths (n = 9)a | 12 mths (n = 9)a | |
| Collagen (%) | 69 ± 3 | 62 ± 2 | 61 ± 4 | 59 ± 2 | 63 ± 3 | 61 ± 2 |
| HP (mmol/mol collagen)b | 298 ± 28 | 322 ± 25 | 314 ± 23 | 267 ± 21 | 254 ± 28 | 292 ± 22 |
| LP (mmol/mol collagen)b | 24.8 ± 5.0 | 26.5 ± 3.8 | 40.8 ± 4.4 | 28.8 ± 5.1 | 37.0 ± 5.9 | 34.3 ± 3.2 |
| Fluorescence (AU/mol collagen)‡ | 1139 [1096–1185] | 1235 [1176–1297] | 1155 [1124–1187] | 1196 [1161–1232] | 1263 [1191–1339] | 1328 [1285–1372] |
Values are means ±SE or geometric mean [lower limit – upper limit]. Data analyzed by repeated measures two-way ANOVA with baseline adjustment and Tukey-Kramer post hoc test
CON = Control, MRT = moderate load resistance training, HRT = Heavy load resistance training
No time x group interactions. ‡: Main effect of time (p < 0.05)
aOne missing sample due to anti-coagulant therapy. bFive missing pairs of samples due to logistics
CON: n = 9, MRT: n = 11, HRT: n = 8